SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?


To: jopawa who wrote (2210)6/24/1999 8:52:00 PM
From: Anthony Wong  Respond to of 2539
 
John, we may see $33 3/4 again, if bad news keep coming.

Anthony



To: jopawa who wrote (2210)6/24/1999 8:56:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 2539
 
From The New England Journal of Medicine -- June 24, 1999 -- Vol. 340, No. 25

Gastropathy Due to Celecoxib, a Cyclooxygenase-2 Inhibitor
nejm.org:80/content/1999/0340/0025/2005.asp



To: jopawa who wrote (2210)6/25/1999 2:52:00 AM
From: Michael Kucera  Respond to of 2539
 
just filling the gap back to 38 one more time before we head north again for the long rode to 60/share. anything under 40 is a steal IMO.